Circulating cell-free DNA for cancer early detection

Zeng, 2018, Changing cancer survival in China during 2003–15: a pooled analysis of 17 population-based cancer registries, Lancet Glob. Health, 6, e555, 10.1016/S2214-109X(18)30127-X Siegel, 2021, Cancer statistics, 2021, CA Cancer J. Clin., 71, 7, 10.3322/caac.21654 Tanoue, 2015, Lung cancer screening, Am. J. Respir. Crit. Care Med., 191, 19, 10.1164/rccm.201410-1777CI Smith, 2018, Cancer screening in the United States, 2018: a review of current American Cancer Society guidelines and current issues in cancer screening, CA Cancer J. Clin., 68, 297, 10.3322/caac.21446 Rafferty, 2016, Breast cancer screening using tomosynthesis and digital mammography in dense and nondense breasts, JAMA, 315, 1784, 10.1001/jama.2016.1708 Liu, 2017, The clinical research of Thinprep Cytology Test (TCT) combined with HPV-DNA detection in screening cervical cancer, Cell Mol. Biol., 63, 92, 10.14715/cmb/2017.63.2.14 Chen, 2019, Participation and yield of a population-based colorectal cancer screening programme in China, Gut, 68, 1450, 10.1136/gutjnl-2018-317124 Tierney, 2015, Cost-effectiveness of CT screening in the national lung screening trial, N. Engl. J. Med., 372, 387, 10.1056/NEJMc1414726 Miller, 2019, Cancer treatment and survivorship statistics, 2019, CA Cancer J. Clin., 69, 363, 10.3322/caac.21565 Pantel, 2019, Liquid biopsy and minimal residual disease — latest advances and implications for cure, Nat. Rev. Clin. Oncol., 16, 409, 10.1038/s41571-019-0187-3 Heitzer, 2018, Current and future perspectives of liquid biopsies in genomics-driven oncology, Nat. Rev. Genet., 20, 71, 10.1038/s41576-018-0071-5 Ignatiadis, 2021, Liquid biopsy enters the clinic - implementation issues and future challenges, Nat. Rev. Clin. Oncol., 18, 297, 10.1038/s41571-020-00457-x Kahlert, 2014, Identification of double-stranded genomic DNA spanning all chromosomes with mutated KRAS and p53 DNA in the serum exosomes of patients with pancreatic cancer, J. Biol. Chem., 289, 3869, 10.1074/jbc.C113.532267 Thakur, 2014, Double-stranded DNA in exosomes: a novel biomarker in cancer detection, Cell Res., 24, 766, 10.1038/cr.2014.44 Jahr, 2001, DNA fragments in the blood plasma of cancer patients: quantitations and evidence for their origin from apoptotic and necrotic cells, Cancer Res., 61, 1659 Diehl, 2008, Circulating mutant DNA to assess tumor dynamics, Nat. Med., 14, 985, 10.1038/nm.1789 To, 2003, Rapid clearance of plasma Epstein-Barr virus DNA after surgical treatment of nasopharyngeal carcinoma, Clin. Cancer Res., 9, 3254 Yao, 2016, Evaluation and comparison of in vitro degradation kinetics of DNA in serum, urine and saliva: a qualitative study, Gene, 590, 142, 10.1016/j.gene.2016.06.033 Lo, 1999, Rapid clearance of fetal DNA from maternal plasma, Am. J. Hum. Genet., 64, 218, 10.1086/302205 Tamkovich, 2006, Circulating DNA and DNase activity in human blood, Ann. N. Y. Acad. Sci., 1075, 191, 10.1196/annals.1368.026 Botezatu, 2000, Genetic analysis of DNA excreted in urine: a new approach for detecting specific genomic DNA sequences from cells dying in an organism, Clin. Chem., 46, 1078, 10.1093/clinchem/46.8.1078 Reckamp, 2016, A highly sensitive and quantitative test platform for detection of NSCLC EGFR mutations in urine and plasma, J. Thorac. Oncol., 11, 1690, 10.1016/j.jtho.2016.05.035 Diehl, 2005, Detection and quantification of mutations in the plasma of patients with colorectal tumors, Proc. Natl. Acad. Sci. U S A, 102, 16368, 10.1073/pnas.0507904102 Chused, 1972, The clearance and localization of nucleic acids by New Zealand and normal mice, Clin. Exp. Immunol., 12, 465 Greytak, 2020, Harmonizing cell-free DNA collection and processing practices through evidence-based guidance, Clin. Cancer Res., 26, 3104, 10.1158/1078-0432.CCR-19-3015 Thierry, 2016, Origins, structures, and functions of circulating DNA in oncology, Cancer Metastasis Rev., 35, 347, 10.1007/s10555-016-9629-x Kustanovich, 2019, Life and death of circulating cell-free DNA, Cancer Biol. Ther., 20, 1057, 10.1080/15384047.2019.1598759 Cohen, 2018, Detection and localization of surgically resectable cancers with a multi-analyte blood test, Science, 359, 926, 10.1126/science.aar3247 Bettegowda, 2014, Detection of circulating tumor DNA in early- and late-stage human malignancies, Sci. Transl. Med., 16, iii7 Sun, 2015, Plasma DNA tissue mapping by genome-wide methylation sequencing for noninvasive prenatal, cancer, and transplantation assessments, Proc. Natl. Acad. Sci. U S A, 112, E5503, 10.1073/pnas.1508736112 Hestand, 2019, Fetal fraction evaluation in non-invasive prenatal screening (NIPS), Eur. J. Hum. Genet., 27, 198, 10.1038/s41431-018-0271-7 Lo, 2010, Maternal plasma DNA sequencing reveals the genome-wide genetic and mutational profile of the fetus, Sci. Transl. Med., 2, 61ra91, 10.1126/scitranslmed.3001720 Thierry, 2010, Origin and quantification of circulating DNA in mice with human colorectal cancer xenografts, Nucleic Acids Res., 38, 6159, 10.1093/nar/gkq421 Snyder, 2016, Cell-free DNA comprises an in vivo nucleosome footprint that Informs its tissues-of-origin, Cell, 164, 57, 10.1016/j.cell.2015.11.050 Nagata, 2000, Apoptotic DNA fragmentation, Exp. Cell Res., 256, 12, 10.1006/excr.2000.4834 Jiang, 2015, Lengthening and shortening of plasma DNA in hepatocellular carcinoma patients, Proc. Natl. Acad. Sci. U S A, 112, E1317, 10.1073/pnas.1500076112 Underhill, 2016, Fragment length of circulating tumor DNA, PLoS Genet., 12, e1006162, 10.1371/journal.pgen.1006162 Mouliere, 2018, Enhanced detection of circulating tumor DNA by fragment size analysis, Sci. Transl. Med., 10, eaat4921, 10.1126/scitranslmed.aat4921 Gansauge, 2013, Single-stranded DNA library preparation for the sequencing of ancient or damaged DNA, Nat. Protoc., 8, 737, 10.1038/nprot.2013.038 Fiala, 2018, Utility of circulating tumor DNA in cancer diagnostics with emphasis on early detection, BMC Med., 16, 166, 10.1186/s12916-018-1157-9 Abbosh, 2017, Phylogenetic ctDNA analysis depicts early-stage lung cancer evolution, Nature, 545, 446, 10.1038/nature22364 Park, 2017, Characterization of background noise in capture-based targeted sequencing data, Genome Biol., 18, 136, 10.1186/s13059-017-1275-2 Forshew, 2012, Noninvasive identification and monitoring of cancer mutations by targeted deep sequencing of plasma DNA, Sci. Transl. Med., 4, 136ra168, 10.1126/scitranslmed.3003726 Kinde, 2011, Detection and quantification of rare mutations with massively parallel sequencing, Proc. Natl. Acad. Sci. U S A, 108, 9530, 10.1073/pnas.1105422108 Smith, 2017, UMI-tools: modeling sequencing errors in Unique Molecular Identifiers to improve quantification accuracy, Genome Res., 27, 491, 10.1101/gr.209601.116 Newman, 2014, An ultrasensitive method for quantitating circulating tumor DNA with broad patient coverage, Nat. Med., 20, 548, 10.1038/nm.3519 Newman, 2016, Integrated digital error suppression for improved detection of circulating tumor DNA, Nat. Biotechnol., 34, 547, 10.1038/nbt.3520 Phallen, 2017, Direct detection of early-stage cancers using circulating tumor DNA, Sci. Transl. Med., 9, eaan2415, 10.1126/scitranslmed.aan2415 van der Pol, 2019, Toward the early detection of cancer by decoding the epigenetic and environmental fingerprints of cell-free DNA, Cancer Cell, 36, 350, 10.1016/j.ccell.2019.09.003 Zhang, 2021, Pan-cancer circulating tumor DNA detection in over 10,000 Chinese patients, Nat. Commun., 12, 11, 10.1038/s41467-020-20162-8 Rolnik, 2018, Influence of body mass index on fetal fraction increase with gestation and cell-free DNA test failure, Obstet. Gynecol., 132, 436, 10.1097/AOG.0000000000002752 Kolarova, 2021, At preeclampsia diagnosis, total cell-free DNA concentration is elevated and correlates with disease severity, J. Am. Heart Assoc., 10, e021477, 10.1161/JAHA.121.021477 Jaiswal, 2019, Clonal hematopoiesis in human aging and disease, Science, 366, eaan4673, 10.1126/science.aan4673 Genovese, 2014, Clonal hematopoiesis and blood-cancer risk inferred from blood DNA sequence, N. Engl. J. Med., 371, 2477, 10.1056/NEJMoa1409405 Chabon, 2020, Integrating genomic features for non-invasive early lung cancer detection, Nature, 580, 245, 10.1038/s41586-020-2140-0 Köhler, 2020, DNA methylation in epidermal differentiation, aging, and cancer, J. Invest. Dermatol., 140, 38, 10.1016/j.jid.2019.05.011 Chatterjee, 2012, CpG methylation recruits sequence specific transcription factors essential for tissue specific gene expression, Biochim. Biophys. Acta, 1819, 763, 10.1016/j.bbagrm.2012.02.014 Dor, 2018, Principles of DNA methylation and their implications for biology and medicine, Lancet, 392, 777, 10.1016/S0140-6736(18)31268-6 Chen, 2020, Non-invasive early detection of cancer four years before conventional diagnosis using a blood test, Nat. Commun., 11, 3475, 10.1038/s41467-020-17316-z Ziller, 2013, Charting a dynamic DNA methylation landscape of the human genome, Nature, 500, 477, 10.1038/nature12433 Wang, 2013, Tagmentation-based whole-genome bisulfite sequencing, Nat. Protoc., 8, 2022, 10.1038/nprot.2013.118 Meissner, 2005, Reduced representation bisulfite sequencing for comparative high-resolution DNA methylation analysis, Nucleic Acids Res., 33, 5868, 10.1093/nar/gki901 Gu, 2011, Preparation of reduced representation bisulfite sequencing libraries for genome-scale DNA methylation profiling, Nat. Protoc., 6, 468, 10.1038/nprot.2010.190 Maunakea, 2010, Conserved role of intragenic DNA methylation in regulating alternative promoters, Nature, 466, 253, 10.1038/nature09165 Zhao, 2014, Methylated DNA immunoprecipitation and high-throughput sequencing (MeDIP-seq) using low amounts of genomic DNA, Cell. Reprogram., 16, 175, 10.1089/cell.2014.0002 Rauch, 2005, Methylated-CpG island recovery assay: a new technique for the rapid detection of methylated-CpG islands in cancer, Lab. Invest., 85, 1172, 10.1038/labinvest.3700311 Shen, 2019, Preparation of cfMeDIP-seq libraries for methylome profiling of plasma cell-free DNA, Nat. Protoc., 14, 2749, 10.1038/s41596-019-0202-2 Shen, 2018, Sensitive tumour detection and classification using plasma cell-free DNA methylomes, Nature, 563, 579, 10.1038/s41586-018-0703-0 Li, 2009, Sensitive digital quantification of DNA methylation in clinical samples, Nat. Biotechnol., 27, 858, 10.1038/nbt.1559 Guo, 2017, Identification of methylation haplotype blocks aids in deconvolution of heterogeneous tissue samples and tumor tissue-of-origin mapping from plasma DNA, Nat. Genet., 49, 635, 10.1038/ng.3805 Guo, 2015, Profiling DNA methylome landscapes of mammalian cells with single-cell reduced-representation bisulfite sequencing, Nat. Protoc., 10, 645, 10.1038/nprot.2015.039 Liang, 2021, Ultrasensitive detection of circulating tumour DNA via deep methylation sequencing aided by machine learning, Nat. Biomed. Eng., 5, 586, 10.1038/s41551-021-00746-5 Diaz, 2014, Liquid biopsies: genotyping circulating tumor DNA, J. Clin. Oncol., 32, 579, 10.1200/JCO.2012.45.2011 Jammula, 2020, Identification of subtypes of Barrett's esophagus and esophageal adenocarcinoma based on DNA methylation profiles and integration of transcriptome and genome data, Gastroenterology, 158, 1682, 10.1053/j.gastro.2020.01.044 Hahn, 2017, Dietary restriction protects from age-associated DNA methylation and induces epigenetic reprogramming of lipid metabolism, Genome Biol., 18, 56, 10.1186/s13059-017-1187-1 Yang, 2020, Precision medicine in non-small cell lung cancer: current applications and future directions, Semin. Cancer Biol. Cristiano, 2019, Genome-wide cell-free DNA fragmentation in patients with cancer, Nature, 570, 385, 10.1038/s41586-019-1272-6 Ivanov, 2019, Utility of cfDNA fragmentation patterns in designing the liquid biopsy profiling panels to improve their sensitivity, Front. Genet., 10, 194, 10.3389/fgene.2019.00194 Corces, 2018, The chromatin accessibility landscape of primary human cancers, Science, 362, eaav1898, 10.1126/science.aav1898 Polak, 2015, Cell-of-origin chromatin organization shapes the mutational landscape of cancer, Nature, 518, 360, 10.1038/nature14221 Whalley, 2020, Framework for quality assessment of whole genome cancer sequences, Nature communications, 11, 5040, 10.1038/s41467-020-18688-y Xu, 2017, Circulating tumour DNA methylation markers for diagnosis and prognosis of hepatocellular carcinoma, Nat. Mater., 16, 1155, 10.1038/nmat4997 Cai, 2019, Genome-wide mapping of 5-hydroxymethylcytosines in circulating cell-free DNA as a non-invasive approach for early detection of hepatocellular carcinoma, Gut, 68, 2195, 10.1136/gutjnl-2019-318882 Qu, 2019, Detection of early-stage hepatocellular carcinoma in asymptomatic HBsAg-seropositive individuals by liquid biopsy, Proc. Natl. Acad. Sci. U S A, 116, 6308, 10.1073/pnas.1819799116 Chen, 2021, Genome-scale profiling of circulating cell-free DNA signatures for early detection of hepatocellular carcinoma in cirrhotic patients, Cell Res., 31, 589, 10.1038/s41422-020-00457-7 Zhang, 2021, Ultra-sensitive and affordable assay for early detection of primary liver cancer using plasma cfDNA fragmentomics, Hepatology Luo, 2020, Circulating tumor DNA methylation profiles enable early diagnosis, prognosis prediction, and screening for colorectal cancer, Sci. Transl. Med., 12, eaax7533, 10.1126/scitranslmed.aax7533 Imperiale, 2014, Multitarget stool DNA testing for colorectal-cancer screening, N. Engl. J. Med., 370, 1287, 10.1056/NEJMoa1311194 Liang, 2021, Accurate diagnosis of pulmonary nodules using a non-invasive DNA methylation test, J. Clin. Invest., 131, 10, 10.1172/JCI145973 Nuzzo, 2020, Detection of renal cell carcinoma using plasma and urine cell-free DNA methylomes, Nat. Med., 26, 1041, 10.1038/s41591-020-0933-1 Chan, 2017, Analysis of plasma epstein-Barr virus DNA to screen for nasopharyngeal cancer, N. Engl. J. Med., 377, 513, 10.1056/NEJMoa1701717 Lennon, 2020, Feasibility of blood testing combined with PET-CT to screen for cancer and guide intervention, Science, 369, eabb9601, 10.1126/science.abb9601 Liu, 2020, Sensitive and specific multi-cancer detection and localization using methylation signatures in cell-free DNA, Ann. Oncol., 31, 745, 10.1016/j.annonc.2020.02.011 Gao, 2021, Early detection and localization of multiple cancers using a blood-based methylation assay (ELSA-seq), J. Clin. Oncol., 39, 459, 10.1200/JCO.2021.39.3_suppl.459 Sung, 2021, Global cancer statistics 2020: GLOBOCAN estimates of incidence and mortality worldwide for 36 cancers in 185 countries, CA Cancer J. Clin., 71, 209, 10.3322/caac.21660 Church, 2013, Results of initial low-dose computed tomographic screening for lung cancer, N. Engl. J. Med., 368, 1980, 10.1056/NEJMoa1209120 Jemal, 2017, Lung cancer screening with low-dose computed tomography in the United States-2010 to 2015, JAMA Oncol., 3, 1278, 10.1001/jamaoncol.2016.6416 Doria-Rose, 2012, Use of lung cancer screening tests in the United States: results from the 2010 National Health Interview Survey, Cancer Epidemiol. Biomarkers Prev., 21, 1049, 10.1158/1055-9965.EPI-12-0343 Mathios, 2021, Detection and characterization of lung cancer using cell-free DNA fragmentomes, Nat. Commun., 12, 5060, 10.1038/s41467-021-24994-w Hulbert, 2017, Early detection of lung cancer using DNA promoter hypermethylation in plasma and sputum, Clin. Cancer Res., 23, 1998, 10.1158/1078-0432.CCR-16-1371 Mcwilliams, 2013, Probability of cancer in pulmonary nodules detected on first screening CT, N. Engl. J. Med., 369, 910, 10.1056/NEJMoa1214726 Wolf, 2018, Colorectal cancer screening for average-risk adults: 2018 guideline update from the American Cancer Society, CA Cancer J. Clin., 68, 250, 10.3322/caac.21457 Hewitson, 2007, Screening for colorectal cancer using the faecal occult blood test, Hemoccult, Cochrane Database Syst. Rev., 2011 Hewitson, 2008, Cochrane systematic review of colorectal cancer screening using the fecal occult blood test (hemoccult): an update, Am. J. Gastroenterol., 103, 1541, 10.1111/j.1572-0241.2008.01875.x Zorzi, 2015, Impact on colorectal cancer mortality of screening programmes based on the faecal immunochemical test, Gut, 64, 784, 10.1136/gutjnl-2014-307508 Sokoro, 2020, Fecal occult blood test for evaluation of symptoms or for diagnostic testing, Am. J. Gastroenterol., 115, 679, 10.14309/ajg.0000000000000560 Buskermolen, 2019, Colorectal cancer screening with faecal immunochemical testing, sigmoidoscopy or colonoscopy: a microsimulation modelling study, BMJ, 367, l5383, 10.1136/bmj.l5383 Regula, 2006, Colonoscopy in colorectal-cancer screening for detection of advanced neoplasia, N. Engl. J. Med., 355, 1863, 10.1056/NEJMoa054967 Imperiale, 2004, Fecal DNA versus fecal occult blood for colorectal-cancer screening in an average-risk population, N. Engl. J. Med., 351, 2704, 10.1056/NEJMoa033403 Ahlquist, 2015, Multi-target stool DNA test: a new high bar for noninvasive screening, Dig. Dis. Sci., 60, 623, 10.1007/s10620-014-3451-5 Piscitello, 2020, Estimating the impact of differential adherence on the comparative effectiveness of stool-based colorectal cancer screening using the CRC-AIM microsimulation model, PLoS One, 15, e0244431, 10.1371/journal.pone.0244431 Song, 2017, The performance of the SEPT9 gene methylation assay and a comparison with other CRC screening tests: a meta-analysis, Sci. Rep., 7, 3032, 10.1038/s41598-017-03321-8 Sun, 2019, The role of m SEPT9 in screening, diagnosis, and recurrence monitoring of colorectal cancer, BMC Cancer, 19, 450, 10.1186/s12885-019-5663-8 Lehmann-Werman, 2016, Identification of tissue-specific cell death using methylation patterns of circulating DNA, Proc. Natl. Acad. Sci. U S A, 113, E1826, 10.1073/pnas.1519286113 Church, 2014, Prospective evaluation of methylated SEPT9 in plasma for detection of asymptomatic colorectal cancer, Gut, 63, 317, 10.1136/gutjnl-2012-304149 Barták, 2017, Colorectal adenoma and cancer detection based on altered methylation pattern of SFRP1, SFRP2, SDC2, and PRIMA1 in plasma samples, Epigenetics, 12, 751, 10.1080/15592294.2017.1356957 Sui, 2021, Discovery and validation of methylation signatures in blood-based circulating tumor cell-free DNA in early detection of colorectal carcinoma: a case-control study, Clin. Epigenetics, 13, 26, 10.1186/s13148-020-00985-4 Cai, 2021, A multilocus blood-based assay targeting circulating tumor DNA methylation enables early detection and early relapse prediction of colorectal cancer, Gastroenterology, 161, 2053, 10.1053/j.gastro.2021.08.054 Attwa, 2015, Guide for diagnosis and treatment of hepatocellular carcinoma, World J. Hepatol., 7, 1632, 10.4254/wjh.v7.i12.1632 Forner, 2012, Hepatocellular carcinoma, Lancet, 379, 1245, 10.1016/S0140-6736(11)61347-0 Zhou, 2020, Guidelines for the diagnosis and treatment of hepatocellular carcinoma (2019 edition), Liver Cancer, 9, 682, 10.1159/000509424 Omata, 2017, Asia–Pacific clinical practice guidelines on the management of hepatocellular carcinoma: a 2017 update, Hepatol. Int., 11, 317, 10.1007/s12072-017-9799-9 Singal, 2009, Meta-analysis: surveillance with ultrasound for early-stage hepatocellular carcinoma in patients with cirrhosis, Aliment. Pharmacol. Ther., 30, 37, 10.1111/j.1365-2036.2009.04014.x Moss, 2018, Comprehensive human cell-type methylation atlas reveals origins of circulating cell-free DNA in health and disease, Nature communications, 9, 5068, 10.1038/s41467-018-07466-6 Kanwal, 2019, Surveillance for hepatocellular carcinoma: current best practice and future direction, Gastroenterology, 157, 54, 10.1053/j.gastro.2019.02.049 Zhang, 2007, Predicting hepatocellular carcinoma by detection of aberrant promoter methylation in serum DNA, Clin. Cancer Res., 13, 2378, 10.1158/1078-0432.CCR-06-1900 Kisiel, 2019, Hepatocellular carcinoma detection by plasma methylated DNA: discovery, phase I pilot, and phase II clinical validation, Hepatology, 69, hep.30244, 10.1002/hep.30244 Luo, 2022, Cell-free DNA methylation markers for differential diagnosis of hepatocellular carcinoma, BMC Med., 20, 8, 10.1186/s12916-021-02201-3 Branco, 2011, Uncovering the role of 5-hydroxymethylcytosine in the epigenome, Nat. Rev. Genet., 13, 7, 10.1038/nrg3080 Song, 2016, Comparison of genome-scale DNA methylation profiles in hepatocellular carcinoma by viral status, Epigenetics, 11, 464, 10.1080/15592294.2016.1151586 Okamoto, 2014, Hepatitis virus infection affects DNA methylation in mice with humanized livers, Gastroenterology, 146, 562, 10.1053/j.gastro.2013.10.056 Moch, 2013, An overview of renal cell cancer: pathology and genetics, Semin. Cancer Biol., 23, 3, 10.1016/j.semcancer.2012.06.006 Siegel, 2019, Cancer statistics, 2019, CA Cancer J. Clin., 69, 7, 10.3322/caac.21551 Schoots, 2017, Bosniak classification for complex renal cysts reevaluated: a systematic review, J. Urol., 198, 12 de Martino, 2012, Serum cell-free DNA in renal cell carcinoma, Cancer, 118, 82, 10.1002/cncr.26254 Skrypkina, 2016, Concentration and methylation of cell-free DNA from blood plasma as diagnostic markers of renal cancer, Dis. Markers, 2016, 1, 10.1155/2016/3693096 Zill, 2018, The landscape of actionable genomic alterations in cell-free circulating tumor DNA from 21,807 advanced cancer patients, Clin. Cancer Res., 24, 3528, 10.1158/1078-0432.CCR-17-3837 De Mattos-Arruda, 2015, Cerebrospinal fluid-derived circulating tumour DNA better represents the genomic alterations of brain tumours than plasma, Nat. Commun., 6, 8839, 10.1038/ncomms9839 Nassiri, 2020, Detection and discrimination of intracranial tumors using plasma cell-free DNA methylomes, Nat. Med., 26, 1044, 10.1038/s41591-020-0932-2 Hoang-Xuan, 2015, Diagnosis and treatment of primary CNS lymphoma in immunocompetent patients: guidelines from the European Association for Neuro-Oncology, Lancet Oncol., 16, 322, 10.1016/S1470-2045(15)00076-5 Miller, 2019, Tracking tumour evolution in glioma through liquid biopsies of cerebrospinal fluid, Nature, 565, 654, 10.1038/s41586-019-0882-3 Cohen, 2017, Combined circulating tumor DNA and protein biomarker-based liquid biopsy for the earlier detection of pancreatic cancers, Proc. Natl. Acad. Sci. U S A, 114, 10202, 10.1073/pnas.1704961114 Guler, 2020, Detection of early stage pancreatic cancer using 5-hydroxymethylcytosine signatures in circulating cell free DNA, Nat. Commun., 11, 5270, 10.1038/s41467-020-18965-w Widschwendter, 2017, The potential of circulating tumor DNA methylation analysis for the early detection and management of ovarian cancer, Genome Med., 9, 116, 10.1186/s13073-017-0500-7 Qin, 2019, Discovery, validation, and application of novel methylated DNA markers for detection of esophageal cancer in plasma, Clin. Cancer Res., 25, 7396, 10.1158/1078-0432.CCR-19-0740 Provenzale, 2020, NCCN guidelines insights: colorectal cancer screening, version 2.2020: featured updates to the NCCN guidelines, J. Natl. Compr. Cancer Netw., 18, 1312, 10.6004/jnccn.2020.0048 Telli, 2019, NCCN guidelines updates: breast cancer, J. Natl. Compr. Cancer Netw., 17, 552 Partridge, 2014, Cervical cancer screening, J. Natl. Compr. Cancer Netw., 12, 333, 10.6004/jnccn.2014.0035 Wood, 2015, Lung cancer screening, version 1.2015, J. Natl. Compr. Cancer Netw., 13, 23, 10.6004/jnccn.2015.0006 Liu, 2019 Klein, 2021, Clinical validation of a targeted MethylationBased multi-cancer early detection test, AACR, 1167 Beer, 2021, Interim results of PATHFINDER, a clinical use study using a methylation-based multi-cancer early detection test, J. Clin. Oncol., 39, 3010, 10.1200/JCO.2021.39.15_suppl.3010 Pepe, 2001, Phases of biomarker development for early detection of cancer, J. Natl. Cancer Inst., 93, 1054, 10.1093/jnci/93.14.1054 Liu, 2021, Transforming the landscape of early cancer detection using blood tests—commentary on current methodologies and future prospects, Br. J. Cancer, 124, 1475, 10.1038/s41416-020-01223-7 Reinert, 2019, Analysis of plasma cell-free DNA by ultradeep sequencing in patients with stages I to III colorectal cancer, JAMA Oncol., 5, 1124, 10.1001/jamaoncol.2019.0528 Christensen, 2019, Early detection of metastatic relapse and monitoring of therapeutic efficacy by ultra-deep sequencing of plasma cell-free DNA in patients with urothelial bladder carcinoma, J. Clin. Oncol., 37, 1547, 10.1200/JCO.18.02052 Razavi, 2019, High-intensity sequencing reveals the sources of plasma circulating cell-free DNA variants, Nat. Med., 25, 1928, 10.1038/s41591-019-0652-7 Sanchez, 2018, New insights into structural features and optimal detection of circulating tumor DNA determined by single-strand DNA analysis, NPJ Genomic Med., 3, 31, 10.1038/s41525-018-0069-0 Eraslan, 2019, Deep learning: new computational modelling techniques for genomics, Nat. Rev. Genet., 20, 389, 10.1038/s41576-019-0122-6 Ko, 2018, Machine learning to detect signatures of disease in liquid biopsies – a user's guide, Lab. Chip, 18, 395, 10.1039/C7LC00955K Sharif, 2020, A comprehensive review on multi-organs tumor detection based on machine learning, Pattern Recognit. Lett., 131, 30, 10.1016/j.patrec.2019.12.006 Beshnova, 2020, De novo prediction of cancer-associated T cell receptors for noninvasive cancer detection, Sci. Transl. Med., 12, eaaz3738, 10.1126/scitranslmed.aaz3738 Dejea, 2018, Patients with familial adenomatous polyposis harbor colonic biofilms containing tumorigenic bacteria, Science, 359, 592, 10.1126/science.aah3648 Morgillo, 2018, Carcinogenesis as a result of multiple inflammatory and oxidative hits: a comprehensive review from tumor microenvironment to gut microbiota, Neoplasia, 20, 721, 10.1016/j.neo.2018.05.002 Thomas, 2020, Microbiota in pancreatic health and disease: the next Frontier in microbiome research, Nat. Rev. Gastroenterol. Hepatol., 17, 53, 10.1038/s41575-019-0242-7 Janney, 2020, Host-microbiota maladaptation in colorectal cancer, Nature, 585, 509, 10.1038/s41586-020-2729-3 Poore, 2020, Microbiome analyses of blood and tissues suggest cancer diagnostic approach, Nature, 579, 567, 10.1038/s41586-020-2095-1 Liu, 2019, Low-cost thermophoretic profiling of extracellular-vesicle surface proteins for the early detection and classification of cancers, Nat. Biomed. Eng., 3, 183, 10.1038/s41551-018-0343-6 Shurtleff, 2018, Extracellular vesicles and cancer: caveat lector, Annu. Rev. Cancer Biol., 2, 395, 10.1146/annurev-cancerbio-030617-050519 Fehlmann, 2020, Evaluating the use of circulating MicroRNA profiles for lung cancer detection in symptomatic patients, JAMA Oncol., 6, 714, 10.1001/jamaoncol.2020.0001 Ying, 2020, Development of a serum miRNA panel for detection of early stage non-small cell lung cancer, Proc. Natl. Acad. Sci. U S A, 117, 25036, 10.1073/pnas.2006212117 Zhou, 2011, Plasma microRNA panel to diagnose hepatitis B virus-related hepatocellular carcinoma, J. Clin. Oncol., 29, 4781, 10.1200/JCO.2011.38.2697 Kahraman, 2018, MicroRNA in diagnosis and therapy monitoring of early-stage triple-negative breast cancer, Sci. Rep., 8, 11584, 10.1038/s41598-018-29917-2 Snoek, 2019, Genome-wide microRNA analysis of HPV-positive self-samples yields novel triage markers for early detection of cervical cancer, Int. J. Cancer, 144, 372, 10.1002/ijc.31855 Tit, 2017 Pashayan, 2018, Cost-effectiveness and benefit-to-harm ratio of risk-stratified screening for breast cancer: a life-table aaamodel, JAMA Oncol., 4, 1504, 10.1001/jamaoncol.2018.1901 Yeh, 2016, Gastric adenocarcinoma screening and prevention in the era of new biomarker and endoscopic technologies: a cost-effectiveness analysis, Gut, 65, 563, 10.1136/gutjnl-2014-308588 Ten Haaf, 2017, Risk prediction models for selection of lung cancer screening candidates: a retrospective validation study, PLoS Med., 14, e1002277, 10.1371/journal.pmed.1002277 Pashayan, 2019, Overestimation of the benefit-to-harm ratio of risk-based mammography screening in the United Kingdom-reply, JAMA Oncol., 5, 428, 10.1001/jamaoncol.2018.6504 Esserman, 2018, Precision risk-based screening might maximize benefit and minimize harm, Nat. Rev. Clin. Oncol., 15, 661, 10.1038/s41571-018-0093-0 Callender, 2019, Polygenic risk-tailored screening for prostate cancer: a benefit-harm and cost-effectiveness modelling study, PLoS Med., 16, e1002998, 10.1371/journal.pmed.1002998 So, 2021, Development and validation of a serum microRNA biomarker panel for detecting gastric cancer in a high-risk population, Gut, 70, 829, 10.1136/gutjnl-2020-322065 Payne, 2018, Cost-effectiveness analyses of genetic and genomic diagnostic tests, Nat. Rev. Genet., 19, 235, 10.1038/nrg.2017.108 Dillon, 2018, Family history-based colorectal cancer screening in Australia: a modelling study of the costs, benefits, and harms of different participation scenarios, PLoS Med., 15, e1002630, 10.1371/journal.pmed.1002630 Kastelein, 2015, Surveillance in patients with long-segment Barrett's oesophagus: a cost-effectiveness analysis, Gut, 64, 864, 10.1136/gutjnl-2014-307197 Cadier, 2017, Early detection and curative treatment of hepatocellular carcinoma: a cost-effectiveness analysis in France and in the United States, Hepatology, 65, 1237, 10.1002/hep.28961 Kim, 2017, Optimal cervical cancer screening in women vaccinated against human papillomavirus, J. Natl. Cancer Inst., 109, djw216, 10.1093/jnci/djw216